In recent years, under the background of high-frequency policy guidance, the promotion of healthy China's industrial development strategy and the gradual emergence of an aging population, China's pharmaceutical industry is gradually ushered in a new development cycle. Among them, biopharmaceuticals, as a strategic emerging industry, has the characteristics of high technology content, high added value, low energy consumption and knowledge-intensive, and the market prospect is even broader. According to statistics, the biopharmaceutical industry's sales are growing at an average rate of 25%-30% per year, making it one of the fastest growing industries.
Compound growth rate reached 18.1%
Biopharmaceuticals are becoming a market affluent with trillions of dollars in value
Nowadays, the bio-pharmaceutical industry is rapidly developing from a high-tech industry with potential for development to a high-tech pillar industry, becoming an important part of high-end manufacturing. It is regarded as a sunrise industry and is known as the gem of the new round of technological revolution. The development momentum is very rapid. Some institutions predict that the compound growth rate of China's bio-pharmaceutical industry will reach 18.1%. By 2020, China's bio-pharmaceutical industry is expected to form a market scale of 8 trillion yuan, which is becoming a market enthusiasm with trillions of dollars worth of value.
In China, biopharmaceuticals are welcoming a new era of development under the support of favorable policies and the promotion of advanced technologies. In recent years, China has attached great importance to the innovation and development of the bio-pharmaceutical industry. Many of the policy documents issued have provided overall, forward-looking and fundamental guidance for the innovation and development of the bio-pharmaceutical industry.
For example, “Healthy China†has risen to a national strategy, and a feast of 10 trillion yuan of industrial investment has been launched; “Made in China 2025†has made biopharmaceuticals a key development area, and continues to accelerate the cultivation of strategic emerging industries such as biopharmaceuticals as a pillar industry of the national economy. . The implementation of these major policies has provided strong policy and financial support for the innovation and development of the biopharmaceutical industry.
Driven by the dual benefits of policy and market environment, China's biopharmaceutical industry has ushered in tremendous development opportunities. In the next decade, the pharmaceutical innovation industry will usher in a huge qualitative change and become the main line of development. However, opportunities and challenges coexist. Biopharmaceuticals is also an investment field with large investment, long cycle, slow effect and high risk. How to improve production efficiency, reduce production costs and shorten the time to market for new products are all important concerns of enterprises. aspect. So in the face of huge market opportunities and challenges, how can companies take advantage of the trend?
The author was informed that on September 4-6, 2018, hosted by China Bio-fermentation Industry Association, Shanghai Xinshi Exhibition Service Co., Ltd. hosted the 2018 6th Shanghai International Bio-fermentation Products and Technology Equipment Exhibition (hereinafter referred to as “Shanghai Bio-fermentation†The exhibition will be held at the Shanghai New International Expo Center. At that time, people of insight will gather together to guide the development of the biopharmaceutical industry.
Focus on biopharmaceutical industry new products, new technologies, new processes Shanghai Bio Fermentation Exhibition will create a new era of biopharmaceuticals
Recently, a film about the medical theme "I am not a drug god" was released, 12 days, and the box office broke 2.5 billion! This has made the innovation and research of medicine and bio-pharmaceuticals attract attention from all walks of life. The lingering surviving of "I am not a drug god", the innovative research and development of biopharmaceuticals is the eternal theme of the development of the pharmaceutical industry. The author is informed that the Shanghai Bio-fermentation Exhibition, as the global "big drama" in the global bio-fermentation industry, will gather the bio-pharmaceutical industry. New products, new technologies, new processes, and new ideas will surely bring new interpretations to the innovation and development of the biological and pharmaceutical industries.
The scope of the exhibition includes bio-fermentation laboratory equipment, such as breeding equipment, cell fermentation tanks, cell culture systems, cell reactors, online detectors, etc.; biological products such as proteins, peptides, antigens, antibodies, vaccines, etc.; engineering technology Equipment, such as fermenters, control systems, instrumentation, drying equipment, cooling equipment, heat exchange equipment, mixing equipment, etc.
Under the strong support of the policy, 2018-2022 will be a good opportunity for the innovation and development of China's biological and pharmaceutical industries. Biological fermentation is an indispensable component of the pharmaceutical, biopharmaceutical, bioengineering, cell engineering, and laboratory equipment industries. It is bound to usher in tremendous development opportunities. Based on the “window†of the development of the bio-pharmaceutical industry, the Shanghai Bio-fermentation Exhibition will set off a new wave for the development of pharmaceutical innovation.
It is understood that the exhibition area of ​​Shanghai Bio-fermentation Exhibition will reach 30,000 square meters. It is committed to building a platform for the bio-fermentation industry and related medicine to establish a technical exchange, promote cooperation, expand upstream and downstream trade, and enhance brand and corporate reputation. Comprehensive exhibition of bio-fermentation industry chain.
In this annual feast, the bio-pharmaceutical industry big coffee, bio-engineering/cell and vaccine giants, and research institutes will all be present. Such as AstraZeneca, Harbin Pharmaceutical Group, Fosun Pharma, Qilu Pharmaceutical, Xinhua Pharmaceutical, Roche, Shanghai Pharmaceutical Group, Yangzijiang Medicine, Gilead, Wuhan Huamei, Shanghai Huake Bio, etc. will gather at this exhibition.
The pharmaceutical industry is an important part of the national economy. Now China is moving towards a strong pharmaceutical innovation country. China's "Made in China 2025" issued by China has listed biopharmaceuticals as one of the key areas for promoting development in the next step, emphasizing the development of new target chemical drugs. , antibody drugs, new vaccines, and at the same time committed to breakthroughs in the field of stem cells. How to promote the innovation and development of medicine and bio-pharmaceuticals? This has become the focus of attention in China's pharmaceutical industry. On September 4-6, the Shanghai Bio-fermentation Exhibition held at the Shanghai New International Expo Center will be the annual feast of the bio-fermentation industry. The group will gather and the pharmaceutical companies will find new ideas and new solutions here. 2018 Shanghai Bio Fermentation Exhibition, let us wait and see!
2018 Shanghai Bio Fermentation Exhibition will be your first choice!
Exhibition, visit and consultation 18516018928 Wang Cheng QQ; 2497672464
mailbox: 
Sweep and pre-register the scene to send the gift!
Daily Chemical Bag Making Machine
Daily Chemical Bag Making Machine,Cosmetic Plastic Bag Making Machine,Plastic Bags Machine Making Automatic,Self Sealing Bag Making Machine
Wuxi Shengkun Machinery Co.,Ltd , https://www.skpouchmachine.com